-
Ventricular assist devices (VADs) have revolutionized the treatment of cardiac disease in adults, improving survival for end-stage heart failure patients who would otherwise die and offering bridge to transplant. But the same option is not always available for children, especially babies.
-
Thomas Trotter has been appointed CEO of AngioScore (Alameda, California), effective immediately. He succeeds Ephraim Heller, founder, chairman and CEO, who is retiring from the company.
-
The 5th annual Summer in Seattle (SIS) conference, held here in July, once again was well-attended and featured some of the interventional communitys best-known physicians, addressing a wide range of topics of current interest.
-
Medtronic (Minneapolis) reported early last month its receipt of the CE mark for its Endeavor Drug-Eluting Coronary Stent with Rapid Exchange Delivery System and said it planned to launch the drug-eluting stent (DES) system simultaneously in 40 countries, outside the U.S.
-
Cardiac Science (Irvine, California), a manufacturer of public-access automated external defibrillators, reported that the Securities and Exchange Commission (SEC) has declared effective its statement related to its proposed merger with Quinton Cardiology Systems (Bothell, Washington).
-
Medtronic (Minneapolis) said last month that the FDA has approved its CardioSight Service, a service for cardiologists who are managing heart failure patients to monitor their patients to provide better care over time in order to adequately address problems when they arise.
-
-
If your organization was found to have a high rate of surgical infections, you could expect to face bad publicity, potential malpractice lawsuits, and major problems with the Joint Commission. But are the data telling an accurate story?
-
New York City may have a reputation as a fast-paced metropolis where most people are too busy to give you the time of day, but the emergency department (ED) at Jack D. Weiler Hospital, one of three EDs in Bronxs Montefiore Medical Center, has won over patients with an approach focused on friendliness and TLC.
-
A series of multidisciplinary initiatives has resulted in a 1.3-day decrease in length of stay (LOS) at Hackensack (NJ) University Medical Center (HUMC).
